For this, we used various human breast cancer cell lines, including MCF7 (HR+), SKBR3 (HER2-enriched), MDA-MB-453 (TNBC- luminal/androgen receptor (LAR)), and MDA-MB-231 (TNBC-mesenchymal-claudin low). Here, ERBB2 is linked to breast carcinoma.